170 related articles for article (PubMed ID: 21212431)
1. DNA mismatch repair gene polymorphisms affect survival in pancreatic cancer.
Dong X; Li Y; Hess KR; Abbruzzese JL; Li D
Oncologist; 2011; 16(1):61-70. PubMed ID: 21212431
[TBL] [Abstract][Full Text] [Related]
2. DNA mismatch repair network gene polymorphism as a susceptibility factor for pancreatic cancer.
Dong X; Li Y; Chang P; Hess KR; Abbruzzese JL; Li D
Mol Carcinog; 2012 Jun; 51(6):491-9. PubMed ID: 21681824
[TBL] [Abstract][Full Text] [Related]
3. Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer.
Dong X; Jiao L; Li Y; Evans DB; Wang H; Hess KR; Abbruzzese JL; Li D
J Clin Oncol; 2009 Apr; 27(10):1592-9. PubMed ID: 19237629
[TBL] [Abstract][Full Text] [Related]
4. Association between genetic polymorphisms in DNA mismatch repair-related genes with risk and prognosis of head and neck squamous cell carcinoma.
Nogueira GA; Lourenço GJ; Oliveira CB; Marson FA; Lopes-Aguiar L; Costa EF; Lima TR; Liutti VT; Leal F; Santos VC; Rinck-Junior JA; Lima CS
Int J Cancer; 2015 Aug; 137(4):810-8. PubMed ID: 25598504
[TBL] [Abstract][Full Text] [Related]
5. Differing patterns of genetic instability in mice deficient in the mismatch repair genes Pms2, Mlh1, Msh2, Msh3 and Msh6.
Hegan DC; Narayanan L; Jirik FR; Edelmann W; Liskay RM; Glazer PM
Carcinogenesis; 2006 Dec; 27(12):2402-8. PubMed ID: 16728433
[TBL] [Abstract][Full Text] [Related]
6. Mismatch repair gene polymorphisms and survival in invasive ovarian cancer patients.
Mann A; Hogdall E; Ramus SJ; DiCioccio RA; Hogdall C; Quaye L; McGuire V; Whittemore AS; Shah M; Greenberg D; Easton DF; Ponder BA; Kjaer SK; Gayther SA; Thompson DJ; Pharoah PD; Song H
Eur J Cancer; 2008 Oct; 44(15):2259-65. PubMed ID: 18723338
[TBL] [Abstract][Full Text] [Related]
7. Common variants in mismatch repair genes and risk of invasive ovarian cancer.
Song H; Ramus SJ; Quaye L; DiCioccio RA; Tyrer J; Lomas E; Shadforth D; Hogdall E; Hogdall C; McGuire V; Whittemore AS; Easton DF; Ponder BA; Kjaer SK; Pharoah PD; Gayther SA
Carcinogenesis; 2006 Nov; 27(11):2235-42. PubMed ID: 16774946
[TBL] [Abstract][Full Text] [Related]
8. Activation of Saccharomyces cerevisiae Mlh1-Pms1 Endonuclease in a Reconstituted Mismatch Repair System.
Smith CE; Bowen N; Graham WJ; Goellner EM; Srivatsan A; Kolodner RD
J Biol Chem; 2015 Aug; 290(35):21580-90. PubMed ID: 26170454
[TBL] [Abstract][Full Text] [Related]
9. Common germline variation in mismatch repair genes and survival after a diagnosis of colorectal cancer.
Koessler T; Azzato EM; Perkins B; Macinnis RJ; Greenberg D; Easton DF; Pharoah PD
Int J Cancer; 2009 Apr; 124(8):1887-91. PubMed ID: 19115210
[TBL] [Abstract][Full Text] [Related]
10. Common variants in mismatch repair genes and risk of colorectal cancer.
Koessler T; Oestergaard MZ; Song H; Tyrer J; Perkins B; Dunning AM; Easton DF; Pharoah PD
Gut; 2008 Aug; 57(8):1097-101. PubMed ID: 18364438
[TBL] [Abstract][Full Text] [Related]
11. Associations of Genetic Variations in Mismatch Repair Genes MSH3 and PMS1 with Acute Adverse Events and Survival in Patients with Rectal Cancer Receiving Postoperative Chemoradiotherapy.
Yang J; Huang Y; Feng Y; Li H; Feng T; Chen J; Yin L; Wang W; Wang S; Liu Y; Song Y; Li Y; Jin J; Tan W; Lin D
Cancer Res Treat; 2019 Jul; 51(3):1198-1206. PubMed ID: 30590005
[TBL] [Abstract][Full Text] [Related]
12. [Genetic variations in MLH3 and MSH2 genes are associated with the sensitivity and prognosis in locally advanced rectal cancer patients receiving preoperative chemoradiotherapy].
Yang J; Wang X; Zou SM; Li HM; Xiao Q; Feng YR; Huang Y; Feng T; Chen JN; Lin DX; Li YX; Jin J; Tan W
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):433-440. PubMed ID: 29936769
[No Abstract] [Full Text] [Related]
13. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of
Bowen N; Kolodner RD
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3607-3612. PubMed ID: 28265089
[TBL] [Abstract][Full Text] [Related]
15. Prognostic values of DNA mismatch repair genes in ovarian cancer patients treated with platinum-based chemotherapy.
Zhao C; Li S; Zhao M; Zhu H; Zhu X
Arch Gynecol Obstet; 2018 Jan; 297(1):153-159. PubMed ID: 29063235
[TBL] [Abstract][Full Text] [Related]
16. Population-based study of the association of variants in mismatch repair genes with prostate cancer risk and outcomes.
Langeberg WJ; Kwon EM; Koopmeiners JS; Ostrander EA; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2010 Jan; 19(1):258-64. PubMed ID: 20056646
[TBL] [Abstract][Full Text] [Related]
17. [Correlation between mismatch-repair protein expression and clinicopathologic features in 658 colorectal cancers].
Hu XR; Xu C; Kang Y; Wang T; Zhang Y; Yang XH
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):827-833. PubMed ID: 30423605
[No Abstract] [Full Text] [Related]
18.
Villahermosa D; Christensen O; Knapp K; Fleck O
G3 (Bethesda); 2017 May; 7(5):1463-1473. PubMed ID: 28341698
[TBL] [Abstract][Full Text] [Related]
19. Detection of DNA Mismatch Repair Protein Abnormalities in Sudanese Colorectal Cancer Patients Using Immunohistochemical Methods.
Zakout YM; Lanza G
J Gastrointest Cancer; 2019 Sep; 50(3):530-536. PubMed ID: 29850986
[TBL] [Abstract][Full Text] [Related]
20. Loss of MSH2 and MSH6 due to heterozygous germline defects in MSH3 and MSH6.
Morak M; Käsbauer S; Kerscher M; Laner A; Nissen AM; Benet-Pagès A; Schackert HK; Keller G; Massdorf T; Holinski-Feder E
Fam Cancer; 2017 Oct; 16(4):491-500. PubMed ID: 28528517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
